Factoid: of the 382 biopharmaceuticals approved in China, only 21 (5%) are novel drugs; all the others are knockoffs—i.e. branded generics. Source: http://www.ft.com/intl/cms/s/2/301a779c-302e-11e2-a040-00144feabdc0.html